Stockscreener 앱 받기
17.39%
시간 외 거래:
전일 마감가:
$299.12
열려 있는:
$265
하루 거래량:
9.33M
Relative Volume:
5.35
시가총액:
$65.96B
수익:
$261.22B
순이익/손실:
$5.40B
주가수익비율:
13.49
EPS:
18.3126
순현금흐름:
$3.94B
1주 성능:
-19.00%
1개월 성능:
-14.28%
6개월 성능:
-27.33%
1년 성능:
-21.03%
1일 변동 폭
$245.61
$273.32
1주일 범위
$245.61
$311.34
52주 변동 폭
$245.61
$350.00
시그나 Stock (CI) Company Profile
명칭
Cigna Group
전화
(860) 226-6000
주소
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
CI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
247.10 | 79.84B | 261.22B | 5.40B | 3.94B | 18.31 |
|
UNH
Unitedhealth Group Inc
|
344.75 | 321.81B | 435.16B | 18.37B | 25.27B | 19.16 |
|
CVS
Cvs Health Corp
|
76.69 | 102.23B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
ELV
Elevance Health Inc
|
321.95 | 74.75B | 194.82B | 5.53B | 3.77B | 24.45 |
|
HUM
Humana Inc
|
285.61 | 35.20B | 123.11B | 1.58B | 2.44B | 13.03 |
시그나 Stock (CI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-14 | 개시 | Goldman | Buy |
| 2025-02-06 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | 개시 | Piper Sandler | Overweight |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-03-06 | 개시 | Barclays | Overweight |
| 2024-02-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-01-04 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-18 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2023-06-06 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Neutral |
| 2023-04-05 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | 재개 | Morgan Stanley | Overweight |
| 2022-11-21 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-06-22 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | 개시 | Loop Capital | Hold |
| 2022-05-27 | 재개 | Bernstein | Mkt Perform |
| 2022-05-26 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-05-16 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-05-09 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2022-02-07 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-01-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-12-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | 개시 | Goldman | Neutral |
| 2021-11-17 | 개시 | Seaport Research Partners | Buy |
| 2021-09-27 | 개시 | SVB Leerink | Mkt Perform |
| 2021-09-10 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-08-06 | 재확인 | BofA Securities | Buy |
| 2021-08-06 | 재확인 | Citigroup | Buy |
| 2021-08-06 | 재확인 | Deutsche Bank | Buy |
| 2021-08-06 | 재확인 | Jefferies | Buy |
| 2021-08-06 | 재확인 | Mizuho | Buy |
| 2021-08-06 | 재확인 | Oppenheimer | Outperform |
| 2021-08-06 | 재확인 | Truist | Buy |
| 2021-05-19 | 개시 | Wells Fargo | Equal Weight |
| 2020-07-01 | 개시 | SVB Leerink | Mkt Perform |
| 2020-05-04 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | 다운그레이드 | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | 개시 | Mizuho | Buy |
| 2019-09-30 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Buy |
| 2019-08-06 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | 개시 | UBS | Buy |
| 2019-01-14 | 개시 | Stephens | Overweight |
| 2018-12-24 | 개시 | Edward Jones | Buy |
| 2018-03-13 | 개시 | Bernstein | Mkt Perform |
| 2018-03-08 | 개시 | Barclays | Overweight |
| 2018-01-03 | 개시 | Goldman | Neutral |
| 2017-11-03 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-06-22 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-06-12 | 개시 | Credit Suisse | Outperform |
| 2017-06-07 | 개시 | Morgan Stanley | Overweight |
| 2017-05-08 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-04-05 | 개시 | Deutsche Bank | Buy |
모두보기
시그나 주식(CI)의 최신 뉴스
Cigna flags margin pressure in pharmacy benefit unit over next two years; shares fall - MSN
The Cigna Group Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Cigna’s 2026 pharmacy profits could be dampened by transition to rebate-free model - Healthcare Dive
Cigna shares plunge as company warns of margin pressure in pharmacy-benefit unit - Invezz
Cigna records higher profit as Evernorth business grows - Modern Healthcare News
Earnings call transcript: Cigna Q3 2025 beats forecasts, stock plunges - Investing.com
Cigna (CI) Projects Strong Financial Growth Trajectory - GuruFocus
Cigna Posts Higher Profit, Revenue as Evernorth Business Continues to Grow - The Wall Street Journal
Cigna (CI) Exceeds Q3 Earnings and Revenue Projections - GuruFocus
Cigna posts $1.87 billion in profit, credits Evernorth - Healthcare Finance News
Cigna stock hits 52-week low at 256.66 USD By Investing.com - Investing.com Nigeria
Barclays Maintains Buy Rating and $383 PT on Cigna (CI) - Insider Monkey
Transcript : The Cigna Group, Q3 2025 Earnings Call, Oct 30, 2025 - MarketScreener
Cigna (CI) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Cigna Plunges on Expected Pressure in Pharmacy Benefit Segment - Bloomberg.com
Cigna reaffirms 2025 outlook, posts $1.9B profit in Q3 - Fierce Healthcare
Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight? - ts2.tech
Cigna beats quarterly profit estimates on health services strength - MSN
Strong Q3 Performance Highlights Cigna's (CI) Strategic Growth - GuruFocus
Cigna (CI) Q3 Earnings and Revenues Top Estimates - Yahoo Finance
The Cigna Group Reports Q3 2025 Earnings: EPS of $6.98 and Reven - GuruFocus
Cigna’s (NYSE:CI) Q3: Beats On Revenue - TradingView
Cigna: Q3 Earnings Snapshot - San Francisco Chronicle
Cigna Reports Earnings Thursday. The Stock Is Facing Political Uncertainties. - Barron's
Cigna sinks 10% after warning of margin squeeze in pharmacy benefit unit; Q3 beats - Investing.com Nigeria
Cigna Outpaces Expectations Thanks To Pharmacy Benefits Arm - Finimize
The Cigna Group Reports Strong Third Quarter 2025 Results - TradingView
Cigna Group beats Q3 estimates, reaffirms full-year outlook By Investing.com - Investing.com Canada
Health insurer Cigna beats quarterly profit estimates on health services strength By Reuters - Investing.com
Cigna Group beats Q3 estimates, reaffirms full-year outlook - Investing.com
Earnings Flash (CI) The Cigna Group Posts Q3 Adjusted EPS $7.83 per Share, vs. FactSet Est of $7.64 - MarketScreener
Earnings Flash (CI) The Cigna Group Reports Q3 Revenue $69.75B, vs. FactSet Est of $67.58B - MarketScreener
Cigna Flags Margin Pressure in Pharmacy Benefit Unit Over Next Two Years; Shares Fall - US News Money
The Cigna Group Q3 Profit Increases, Beats Estimates - Nasdaq
Cigna Corp. (CI) Tops Q3 EPS by 19c, Beats on Revenue; Offers FY25 EPS Guidance - StreetInsider
The Cigna Group Reports Strong Third Quarter 2025 Results, Reaffirms 2025 Adjusted EPS Outlook - Yahoo Finance
Cigna Breaks Revenue Records And Raises The Bar For 2025 - Finimize
UnitedHealth's $4.3 Billion Profit Fueled By 'Generosity Of Uncle Sam,' Says Healthcare Activist: Government Drives 78% Of Health Plan Revenue - Benzinga
Is a relief rally coming for The Cigna Group holdersJuly 2025 Snapshot & Free Technical Pattern Based Buy Signals - newser.com
Is The Cigna Group (CGN) stock protected from inflation2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
JPMorgan Maintains Overweight Rating on Cigna (CI) Following Express Scripts Update - Insider Monkey
Will Lower Premiums Affect Cigna's Q3 Earnings? Key Insights Here - TradingView
James Investment Research Inc. Purchases 2,876 Shares of Cigna Group $CI - MarketBeat
Will The Cigna Group stock extend growth storyMarket Trend Review & Precise Buy Zone Tips - newser.com
Cigna’s Rebate-Free Pharmacy Model: Three Realities Behind Its Latest Push to Pop the Gross-to-Net Bubble - Drug Channels
What Express Scripts’ drug rebate phase-out means for PBMs - Modern Healthcare News
Envestnet Asset Management Inc. Increases Position in Cigna Group $CI - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Raises Stake in Cigna Group $CI - MarketBeat
Cigna (CI) Reports Q3: Everything You Need To Know Ahead Of Earnings - FinancialContent
Cigna’s End to Drug Rebates Spurs Questions on Premiums, Impact - Bloomberg Law News
What Cigna Group (CI)'s Shift to a Rebate-Free Pharmacy Model Means For Shareholders - simplywall.st
시그나 (CI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.28%
자본화:
|
볼륨(24시간):